956 related articles for article (PubMed ID: 31100418)
1. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
[TBL] [Abstract][Full Text] [Related]
2. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
[TBL] [Abstract][Full Text] [Related]
3. Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
Zhang X; Gu B; Mei Y; Wen Y; Xia W
J Antibiot (Tokyo); 2015 Feb; 68(2):115-20. PubMed ID: 25182483
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and mortality outcome of carbapenem- and colistin-resistant
Balkhair A; Saadi KA; Adawi BA
IJID Reg; 2023 Jun; 7():1-5. PubMed ID: 36936715
[TBL] [Abstract][Full Text] [Related]
5. Carbapenemase-Encoding Genes and Colistin Resistance in Gram-Negative Bacteria During the COVID-19 Pandemic in Mexico: Results from the Invifar Network.
Garza-Ramos U; Silva-Sánchez J; López-Jácome LE; Hernández-Durán M; Colín-Castro CA; Sánchez-Pérez A; Rodríguez-Santiago J; Morfín-Otero R; Rodriguez-Noriega E; Velázquez-Acosta MD; Vázquez-Larios MDR; Feliciano-Guzmán JM; Rojas-Larios F; Ponce-De-Leon A; Lozano-Garcia M; Choy-Chang EV; López-Gutiérrez E; Molina-Jaimes A; Gil-Veloz M; Corte-Rojas RE; López-Ovilla I; Ramirez-Mis JL; Rodríguez-Balderas DE; Molina-Chavarria A; Padilla-Ibarra C; Quevedo-Ramos MA; Mireles-Dávalos CD; Rodríguez-Medina N; Rubio-Mendoza D; Córdova-Fletes C; Cruz-López F; Becerra-Montejano DA; Mercado-Longoria R; Martínez-Villarreal RT; Barlandas-Rendón NRE; Mena-Ramírez JP; Couoh-May CA; Alcaraz-Espejel M; Adame-Alvarez C; Hernández-Vicente L; Garza-González E
Microb Drug Resist; 2023 Jun; 29(6):239-248. PubMed ID: 36595348
[TBL] [Abstract][Full Text] [Related]
6. Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates.
Choi MJ; Park YK; Peck KR; Ko KS
Int J Antimicrob Agents; 2014 Nov; 44(5):475-6. PubMed ID: 25443890
[No Abstract] [Full Text] [Related]
7. Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.
Meletis G; Oustas E; Botziori C; Kakasi E; Koteli A
New Microbiol; 2015 Jul; 38(3):417-21. PubMed ID: 26147150
[TBL] [Abstract][Full Text] [Related]
8. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
[TBL] [Abstract][Full Text] [Related]
11. Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
Shah PG; Shah SR
J Assoc Physicians India; 2015 Jul; 63(7):14-8. PubMed ID: 26731822
[TBL] [Abstract][Full Text] [Related]
12. First Detection of VIM-4-Producing Pseudomonas aeruginosa and OXA-48-Producing Klebsiella pneumoniae in Northeastern (Annaba, Skikda) Algeria.
Mellouk FZ; Bakour S; Meradji S; Al-Bayssari C; Bentakouk MC; Zouyed F; Djahoudi A; Boutefnouchet N; Rolain JM
Microb Drug Resist; 2017 Apr; 23(3):335-344. PubMed ID: 27314660
[TBL] [Abstract][Full Text] [Related]
13. Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance.
Laishram S; Anandan S; Devi BY; Elakkiya M; Priyanka B; Bhuvaneshwari T; Peter JV; Subramani K; Balaji V
J Chemother; 2016 Aug; 28(4):297-303. PubMed ID: 27461479
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.
Bandy A; Almaeen AH
PLoS One; 2020; 15(6):e0233704. PubMed ID: 32516308
[TBL] [Abstract][Full Text] [Related]
16. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
Vidaillac C; Benichou L; Duval RE
Antimicrob Agents Chemother; 2012 Sep; 56(9):4856-61. PubMed ID: 22751540
[TBL] [Abstract][Full Text] [Related]
17. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.
Kopterides P; Koletsi PK; Michalopoulos A; Falagas ME
Int J Antimicrob Agents; 2007 Nov; 30(5):409-14. PubMed ID: 17851052
[TBL] [Abstract][Full Text] [Related]
18. Emergence of multiple carbapenemase-producing Gram-negative species, colistin-resistant KPC-2-producing Klebsiella pneumoniae ST11, IMP-7-producing Pseudomonas aeruginosa ST357, and OXA-23-producing Acinetobacter baumannii ST1050, in a single patient.
Nishida S; Ishigaki S; Asahara M; Furukawa T; Ono Y
Int J Antimicrob Agents; 2018 Oct; 52(4):512-514. PubMed ID: 30318057
[No Abstract] [Full Text] [Related]
19. Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.
Lee JY; Choi MJ; Choi HJ; Ko KS
Antimicrob Agents Chemother; 2016 Jan; 60(1):609-12. PubMed ID: 26459897
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study.
Matthaiou DK; Michalopoulos A; Rafailidis PI; Karageorgopoulos DE; Papaioannou V; Ntani G; Samonis G; Falagas ME
Crit Care Med; 2008 Mar; 36(3):807-11. PubMed ID: 18431267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
